Advertisement

Mast Cell Apoptosis and Its Regulation

  • Yoseph A. Mekori
  • Karin Hartmann
  • Dean D. Metcalfe
Chapter

Abstract

Mast cells are found almost exclusively in tissues in which they reach phenotypic maturation under certain microenvironmental influences.1,2 The number of mast cells in these tissues under normal conditions is relatively constant.3 Mast cell hyperplasia occurs, however, in several conditions including host responses to parasites and neoplasia; in tissue repair and fibrosis; and in chronic inflammatory conditions associated with the pathology of diseases such as Crohn’s disease and rheumatoid arthritis.4,5 The growth factors required for mast cell proliferation or maturation are well studied, and include IL-3 and the c-kit ligand stem cell factor (SCF) as the principal growth-promoting cytokines. However, less is known about the mechanisms that regulate the viability of mature mast cells and permit mast cell apoptosis.

Keywords

Mast Cell Nerve Growth Factor Stem Cell Factor Human Mast Cell Mast Cell Number 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Galli S J. New concepts about the mast cell. N Engl J Med 1993;328:257–265.PubMedCrossRefGoogle Scholar
  2. 2.
    Metcalfe DD, Mekori YA, Rottem M. Mast cell ontogeny and apoptosis. Exp Dermatol 1995;4:227–230.PubMedCrossRefGoogle Scholar
  3. 3.
    Garriga MM, Friedman M, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988;82:425–430.PubMedCrossRefGoogle Scholar
  4. 4.
    Mekori YA, Zeidan Z. Mast cells in non-allergic inflammatory processes. Isr J Med Sci 1990;26:337–340.PubMedGoogle Scholar
  5. 5.
    Nechushtan H, Razin E. Regulation of mast cell growth and proliferation. Crit Rev Oncol Hematol 1996;23:131–150.PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen JJ, Duke RC, Fadok VA. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267–293.PubMedCrossRefGoogle Scholar
  7. 7.
    Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990;136:593–608.PubMedGoogle Scholar
  8. 8.
    Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst 1994;86:1286–1295.PubMedCrossRefGoogle Scholar
  9. 9.
    Cohen JJ. Apoptosis. Immunol Today 1993;14:126–130.PubMedCrossRefGoogle Scholar
  10. 10.
    Mekori YA, Oh CK, Metcalfe DD. Independent mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 1993;151:3775–3784.PubMedGoogle Scholar
  11. 11.
    Yee NS, Paek I, Besmer P. Role of c-kit ligand in proliferation and suppression of apoptosis in mast cells. Basis for radiosensitivity of white spotting and steel mutants. J Exp Med 1994;179:1777–1787.PubMedCrossRefGoogle Scholar
  12. 12.
    Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond) 1993;362:849–852.CrossRefGoogle Scholar
  13. 13.
    Takano YS, Harmon BV, Kerr JFR. Apoptosis induced by mild hyperthermia in human and murine tumor cell lines: a study using electron microscopy and DNA gel electrophoresis. J Pathol 1991;163:329–336.PubMedCrossRefGoogle Scholar
  14. 14.
    Nagata S. Fas-mediated apoptosis. Adv Exp Med Biol 1996;406:119–124.PubMedGoogle Scholar
  15. 15.
    Cohen JJ. Apoptosis and its regulation. Adv Exp Med Biol 1996;406:11–20.PubMedGoogle Scholar
  16. 16.
    Martin SJ, Lennon SV, Bonham AM, et al. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990;145:1859–1857.PubMedGoogle Scholar
  17. 17.
    Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119–128.PubMedCrossRefGoogle Scholar
  18. 18.
    Shi Y, Glynn JM, Guilbert LJ, et al. Role for c-myc in activation-induced apoptosis cell death in T cell hybridomas. Science 1992;257:212–214.PubMedCrossRefGoogle Scholar
  19. 19.
    Armstrong RC, Aja T, Xiang J, et al. Fas-induced activation of the cell death-related protease CPP32 is inhibitied by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996;271:16850–16855.PubMedCrossRefGoogle Scholar
  20. 20.
    Yonish E, Resnitzky D, Lottern J, et al. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature (Lond) 1991;352:345–348.CrossRefGoogle Scholar
  21. 21.
    Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond) 1993;362:847–849.CrossRefGoogle Scholar
  22. 22.
    Brach MA, de Vos S, Gruss H-J, et al. Prolongation of survival of human polymorphonucelar neutrophils by GM-CSF is caused by inhibition of programmed cell death. Blood 1992;80:2920–2924.PubMedGoogle Scholar
  23. 23.
    Dancescu M, Rubio-Trujillo M, Biron G, et al. Interleukin 4 protects chronic lymphocytic leukemic В cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992;176:1319–1326.PubMedCrossRefGoogle Scholar
  24. 24.
    Bates RC, Buret A, van Helden DF, et al. Apoptosis induced by inhibition of intercellular contacts. J Cell Biol 1994;125:403–415.PubMedCrossRefGoogle Scholar
  25. 25.
    Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993;4:953–961.PubMedGoogle Scholar
  26. 26.
    Korsmeyer SJ. Bcl-2 repressor of lymphocyte death. Immunol Today 1992;13:285–288.PubMedCrossRefGoogle Scholar
  27. 27.
    Boise LH, Gonzalez Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597–608.PubMedCrossRefGoogle Scholar
  28. 28.
    Nunez G, London L, Hockenbery D, et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor deprived hemopoietic cell lines. J Immunol 1990;144:3602–3607.PubMedGoogle Scholar
  29. 29.
    Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with conserved homolog, Bax, that accelerates programed cell death. Cell 1993;74:609–619.PubMedCrossRefGoogle Scholar
  30. 30.
    Zubiaga AM, Munoz E, Huber BT. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol 1992;149:107–112.PubMedGoogle Scholar
  31. 31.
    Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 1992;148:1812–1816.PubMedGoogle Scholar
  32. 32.
    Calderwood SK, Stevenson MA, Hahn GM. Effects of heat on cell calcium and inositol metabolism. Radiât Res 1988;113:414–425.PubMedCrossRefGoogle Scholar
  33. 33.
    Smith CA, Williams GT, Kingston R, et al. Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells. Nature (Lond) 1989;337:181–184.CrossRefGoogle Scholar
  34. 34.
    Tsai M, Takashi T, Thompson H, et al. Induction of mast cell proliferation maturation and herptin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991;88:6382–6386.PubMedCrossRefGoogle Scholar
  35. 35.
    Bianchine PJ, Burd PR, Metcalfe DD. IL-3-dependent mast cells attach to plate-bound vitronectin: demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol 1992;149:3665–3671.PubMedGoogle Scholar
  36. 36.
    Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 1994;152:213–219.PubMedGoogle Scholar
  37. 37.
    Iemura A, Tsai M, Ando A, et al. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994;144:321–328.PubMedGoogle Scholar
  38. 38.
    Caceres-Cortes J, Rajotte D, Dumouchel J, et al. Product of the steel locus suppresses apoptosis in hemopoietic cells. J Biol Chem 1994;269:12084–12091.PubMedGoogle Scholar
  39. 39.
    Hatfield SM, Roehm NW. Cyclosporine and FK506 inhibition of mast cell cytokine production. J Pharmacol Exp Ther 1992;260:680–688.PubMedGoogle Scholar
  40. 40.
    Park SJ, Jun CD, Choi BM, et al. Stem cell factor protects bone marrow-derived cultured mast cells (BMCMC) from cytocidal effect of nitric oxide secreted by fibrobasts in murine BMCMC-fibroblasts coculture. Biochem Mol Biol Int 1996;40:721–729.PubMedGoogle Scholar
  41. 41.
    Zsebo KM, Smith KA, Hartley CA, et al. Radioprotection of mice by rSCF. Proc Natl Acad Sci USA 1992;90:9464–9468.CrossRefGoogle Scholar
  42. 42.
    Rodriguez-Traduchy G, Collins MKL, Garcia I, et al. Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 1992;149:535–540.Google Scholar
  43. 43.
    Mekori YA, Metcalfe DD. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivaton. J Immunol 1994;153:2194–2203.PubMedGoogle Scholar
  44. 44.
    Dubois CM, Ruscetti FW, Stankova J, et al. TGF-β regulates c-kit message stability and cell-surface protein expression in hemopoietic progenitors. Blood 1994;83:3138–3145.PubMedGoogle Scholar
  45. 45.
    Horigome K, Bullock ED, Johnson EM. Effects of nerve growth factor on rat peritoneal mast cells. J Biol Chem 1994;269:2695–2702.PubMedGoogle Scholar
  46. 46.
    Kawamoto K, Okada T, Kannan Y, et al. Nerve growth factor prevents apoptsis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 1995;86:4638–4644.PubMedGoogle Scholar
  47. 47.
    Bullock ED, Johnson EM. Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J. Biol Chem 1996;271:27500–27508.PubMedCrossRefGoogle Scholar
  48. 48.
    Matsuda H, Kannan Y, Ushio H, et al. Nerve growth factor induces development of connective tissue type mast cells in vitro from murine bone marrow cells. J Exp Med 1991;174:7–14.PubMedCrossRefGoogle Scholar
  49. 49.
    Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358–366.PubMedCrossRefGoogle Scholar
  50. 50.
    Yanagida M, Fukamachi H, Ohgami K, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995;86:3705–3714.PubMedGoogle Scholar
  51. 51.
    Yanagida M, Fukamachi H, Takei M, et al. Interferon-γ promotes the survival and FcεRI-mediated histamine release in cultured human mast cells. Immunology 1996;89:547–552.PubMedCrossRefGoogle Scholar
  52. 52.
    Welham MJ, Schrader JW. Steel factor-induced tyrosine phosphorylation in murine mast cells: common elements with IL-3 induced signal transduction pathways. J Immunol 1992;149:2772–2778.PubMedGoogle Scholar
  53. 53.
    Cleveland JL, Dean M, Rosenberg N, et al. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol Cell Biol 1989;9:5685–5695.PubMedGoogle Scholar
  54. 54.
    Kraft AS, Wagner F, Housey GM. Overexpression of protein kinase С beta 1 is not sufficient to induce factor independence in the interleukin-3-dependent myeloid cell line FDC-P1. Oncogene 1990;5:1243–1246.PubMedGoogle Scholar
  55. 55.
    Scheid MP, Lauener RW, Duronio V. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatydylinositol 3-OH kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem J 1995;312:159–162.PubMedGoogle Scholar
  56. 56.
    Scheid MP, Charlton L, Pelech SL, et al. Role of p70 S6 kinase in cytokine-regulated hemopoietic cell survival. Biochem Cell Biol 1996;74:595–600.PubMedCrossRefGoogle Scholar
  57. 57.
    Mekori YA, Oh CK, Dastych J, et al. Characterization of a mast cell line which lacks the extracellular domain of membrane c-kit. Immunology 1997;90:518–525.PubMedCrossRefGoogle Scholar
  58. 58.
    Hughes DPM, Crispe IN. A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J Exp Med 1995;182:1395–1401.PubMedCrossRefGoogle Scholar
  59. 59.
    Schroter M, Lowin В, Borner С, Tschopp J. Regulation of Fas (Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur J Immunol 1995;25:3509–3513.PubMedCrossRefGoogle Scholar
  60. 60.
    Hartmann К, Wagelie-Steffen A, von-Stebut E, et al. Fas (CD95,APO 1) antigen expression and function in murine mast cells. J Immunol 1997;159:4006–4014.PubMedGoogle Scholar
  61. 61.
    Tsai M, Shih LS, Newlands GFJ, et al. The rat c-kit ligand, stem cell factor induces the development of connective tissue-type and mucosal mast cell in vivo. J Exp Med 1992;174:125–131.CrossRefGoogle Scholar
  62. 62.
    Galli SJ, Iemura A, Garlick DS, et al. Reversible expansion of primate mast cell population in vivo by stem cell factor. J Clin Invest 1993;91:148–152.PubMedCrossRefGoogle Scholar
  63. 63.
    Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocytes hyperplasia and functional activation in vivo. J Exp Med 1996;183:2681–2686.PubMedCrossRefGoogle Scholar
  64. 64.
    Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast cell growth factor (c-kit ligand) in cutaneous mastocytosis. New Engl J Med 1993;328:1302–1307.PubMedCrossRefGoogle Scholar
  65. 65.
    Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560–10564.PubMedCrossRefGoogle Scholar
  66. 66.
    Longley BJ, Tyrrell L, Lu SZ, et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312–314.PubMedCrossRefGoogle Scholar
  67. 67.
    Lavker RM, Schechter NM. Cutaneous mast cell depletion results from topical corticosteroids usage. J Immunol 1985;135:2368–2373.PubMedGoogle Scholar
  68. 68.
    Goldsmith P, McGarity B, Walls AF, et al. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990;35:1409–1413.PubMedCrossRefGoogle Scholar
  69. 69.
    Finotto S, Mekori YA, Metcalfe DD. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells. J Clin Invest 1997;99:1721–1728.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1999

Authors and Affiliations

  • Yoseph A. Mekori
  • Karin Hartmann
  • Dean D. Metcalfe

There are no affiliations available

Personalised recommendations